Kenneth M. Bahrt

Overview

Kenneth M. Bahrt received an average of $490K in total compensation, including $370K in salary, at Outlook Therapeutics from 2016 to 2018. Kenneth Bahrt also received an average of $1M at SAVIENT PHARMACEUTICALS between 2011 and 2012.

Source: SEC filings on August 1, 2019, August 17, 2018, and April 29, 2013.

Related executives

We found 11 more executives who work or worked at Outlook Therapeutics and SAVIENT PHARMACEUTICALS.

C Trenary

Outlook Therapeutics

Chief Executive Officer

Terry Dagnon

Outlook Therapeutics

Former Chief Operations Officer

Jeff Evanson

Outlook Therapeutics

Chief Commercial Officer

Lawrence Kenyon

Outlook Therapeutics

Chief Financial Officer

Pankaj Mohan

Outlook Therapeutics

Chief Executive Officer

Stephen McAndrew

Outlook Therapeutics

Former Senior Vice President, Business Strategy & Development

Kogan Bao

Outlook Therapeutics

Former Vice President, Analytical Sciences

Louis Ferrari

SAVIENT PHARMACEUTICALS

Chief Executive Officer

News

You may also like